BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oumata N, Lu K, Teng Y, Cavé C, Peng Y, Galons H, Roques BP. Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules. Eur J Med Chem 2022;240:114578. [PMID: 35841881 DOI: 10.1016/j.ejmech.2022.114578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Fu J, Li J, Sun Y, Liu S, Song F, Liu Z. In-depth investigation of the mechanisms of Schisandra chinensis polysaccharide mitigating Alzheimer's disease rat via gut microbiota and feces metabolomics. Int J Biol Macromol 2023;232:123488. [PMID: 36731694 DOI: 10.1016/j.ijbiomac.2023.123488] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Hassan AS, Morsy NM, Aboulthana WM, Ragab A. Exploring novel derivatives of isatin-based Schiff bases as multi-target agents: design, synthesis, in vitro biological evaluation, and in silico ADMET analysis with molecular modeling simulations. RSC Adv 2023;13:9281-303. [PMID: 36950709 DOI: 10.1039/d3ra00297g] [Reference Citation Analysis]
3 Waiker DK, Verma A, Saraf P, T A G, Krishnamurthy S, Chaurasia RN, Shrivastava SK. Development and Evaluation of Some Molecular Hybrids of N-(1-Benzylpiperidin-4-yl)-2-((5-phenyl-1,3,4-oxadiazol-2-yl)thio) as Multifunctional Agents to Combat Alzheimer's Disease. ACS Omega 2023;8:9394-414. [PMID: 36936338 DOI: 10.1021/acsomega.2c08061] [Reference Citation Analysis]
4 Hassan AS, Morsy NM, Aboulthana WM, Ragab A. In vitro enzymatic evaluation of some pyrazolo[1,5-a]pyrimidine derivatives: Design, synthesis, antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic activities with molecular modeling simulation. Drug Dev Res 2023;84:3-24. [PMID: 36380556 DOI: 10.1002/ddr.22008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS. Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease. Cell Signal 2023;102:110539. [PMID: 36455831 DOI: 10.1016/j.cellsig.2022.110539] [Reference Citation Analysis]
6 Kola A, Lamponi S, Currò F, Valensin D. A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity. Int J Mol Sci 2023;24. [PMID: 36768823 DOI: 10.3390/ijms24032500] [Reference Citation Analysis]
7 Okumura H, Kawasaki T, Nakamura K. Probing protein misfolding and dissociation with an infrared free-electron laser. Methods Enzymol 2023;679:65-96. [PMID: 36682873 DOI: 10.1016/bs.mie.2022.08.047] [Reference Citation Analysis]
8 Rasheed A, Zaheer AB, Munawwar A, Sarfraz Z, Sarfraz A, Robles-Velasco K, Cherrez-Ojeda I. The Allosteric Antagonist of the Sigma-2 Receptors-Elayta (CT1812) as a Therapeutic Candidate for Mild to Moderate Alzheimer's Disease: A Scoping Systematic Review. Life (Basel) 2022;13. [PMID: 36675950 DOI: 10.3390/life13010001] [Reference Citation Analysis]
9 Akhtar A, Gupta SM, Dwivedi S, Kumar D, Shaikh MF, Negi A. Preclinical Models for Alzheimer's Disease: Past, Present, and Future Approaches. ACS Omega 2022;7:47504-17. [PMID: 36591205 DOI: 10.1021/acsomega.2c05609] [Reference Citation Analysis]
10 Nejabati HR, Roshangar L. Kaempferol as a potential neuroprotector in Alzheimer's disease. J Food Biochem 2022;46:e14375. [PMID: 35929364 DOI: 10.1111/jfbc.14375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Van Manh N, Hoang V, Ngo VT, Kang S, Jeong JJ, Ha H, Kim H, Kim Y, Ann J, Lee J. Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents. European Journal of Medicinal Chemistry 2022;244:114837. [DOI: 10.1016/j.ejmech.2022.114837] [Reference Citation Analysis]